Benzinga | May 6, 2021 05:14PM EDT

Corcept Therapeutics Q1 Adj. EPS $0.20 Misses $0.21 Estimate, Sales $79.40M Miss $91.81M Estimate

Corcept Therapeutics (NASDAQ:CORT) reported quarterly earnings of $0.20 per share which missed the analyst consensus estimate of $0.21 by 4.76 percent. This is a 41.18 percent decrease over earnings of $0.34 per share from the same period last year. The company reported quarterly sales of $79.40 million which missed the analyst consensus estimate of $91.81 million by 13.52 percent. This is a 14.85 percent decrease over sales of $93.25 million the same period last year.